Literature DB >> 12744526

Screening of substrate analogs as potential enzyme inhibitors for the arginine kinase of Trypanosoma cruzi.

Claudio A Pereira1, Guillermo D Alonso, Soledad Ivaldi, León A Bouvier, Héctor N Torres, Mirtha M Flawiá.   

Abstract

Arginine kinase catalyzes the transphosphorylation between phosphoarginine and ADP. Phosphoarginine is involved in temporal ATP buffering and inorganic phosphate regulation. Trypanosoma cruzi arginine kinase phosphorylates only L-arginine (specific activity 398.9 x mUE-min(-1) x mg(-1)), and is inhibited by the arginine analogs, agmatine, canavanine, nitroarginine, and homoarginine. Canavanine and homoarginine also produce a significant inhibition of the epimastigote culture growth (79.7% and 55.8%, respectively). Inhibition constants were calculated for canavanine and homoarginine (7.55 and 6.02 mM, respectively). In addition, two novel guanidino kinase activities were detected in the epimastigote soluble extract. The development of the arginine kinase inhibitors of T. cruzi could be an important feature because the phosphagens biosynthetic pathway in trypanosomatids is different from the one in their mammalian hosts.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12744526     DOI: 10.1111/j.1550-7408.2003.tb00247.x

Source DB:  PubMed          Journal:  J Eukaryot Microbiol        ISSN: 1066-5234            Impact factor:   3.346


  4 in total

Review 1.  Phosphagen kinases of parasites: unexplored chemotherapeutic targets.

Authors:  Blanca R Jarilla; Takeshi Agatsuma
Journal:  Korean J Parasitol       Date:  2010-12-16       Impact factor: 1.341

2.  Singular features of trypanosomatids' phosphotransferases involved in cell energy management.

Authors:  Claudio A Pereira; León A Bouvier; María de Los Milagros Cámara; Mariana R Miranda
Journal:  Enzyme Res       Date:  2011-04-04

3.  Identification and functional characterization of a novel arginine/ornithine transporter, a member of a cationic amino acid transporter subfamily in the Trypanosoma cruzi genome.

Authors:  Cristina Henriques; Megan P Miller; Marcos Catanho; Técia Maria Ulisses de Carvalho; Marco Aurélio Krieger; Christian M Probst; Wanderley de Souza; Wim Degrave; Susan Gaye Amara
Journal:  Parasit Vectors       Date:  2015-06-25       Impact factor: 3.876

Review 4.  Kinases as druggable targets in trypanosomatid protozoan parasites.

Authors:  Christopher Merritt; Lisseth E Silva; Angela L Tanner; Kenneth Stuart; Michael P Pollastri
Journal:  Chem Rev       Date:  2014-10-07       Impact factor: 60.622

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.